NERISSA KREHER
CIK 1741850 · Chief Medical Officer · last filed 2026-07-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$843.3K
Companies
4
Total Filings
43
Lifetime Open-Market Net
-$988.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XERS | Director | 33,582 | $8.39 | $281.8K | $0 | 1 | 2026-07-02 |
| RZLT | Director | 58,576 | $4.62 | $270.6K | $10.0K | 7 | 2025-11-21 |
| TRDA | Chief Medical Officer | 41,330 | $7.04 | $291.0K | -$998.2K | 15 | 2023-09-06 |
| Tectonic Therapeutic, Inc. (AVRO) Delisted | Chief Medical Officer | 245 | $16.80 | $4.1K | $0 | 1 | 2018-10-10 |
Recent Filings · Page 3 of 5
43 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-04-08 | TRDA | Notice (144) | −5,689 | -$76.8K | EDGAR |
| 2024-04-05 | TRDA | Notice (144) | −7,500 | -$102.6K | EDGAR |
| 2024-01-25 | RZLT | Grant (A) | — | $0 | EDGAR |
| 2023-09-06 | TRDA | Notice (144) | −892 | -$12.6K | EDGAR |
| 2023-09-06 | TRDA | Mixed | +12,907 | -$17.8K | EDGAR |
| 2023-08-04 | TRDA | Mixed | — | -$338.1K | EDGAR |
| 2023-08-02 | TRDA | Notice (144) | −26,710 | -$452.5K | EDGAR |
| 2023-04-19 | TRDA | Grant (A) | +14,200 | $0 | EDGAR |
| 2023-03-03 | TRDA | Mixed | +25,814 | -$28.3K | EDGAR |
| 2023-01-03 | TRDA | Sell (S) | −5,200 | -$69.9K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.